← Back to All US Stocks

MPT Stock Analysis 2026 - MEDICAL PROPERTIES TRUST INC AI Rating

MPT NYSE Real Estate Investment Trusts CIK: 0001287865
Recently Updated • Analysis: Apr 2, 2026 • SEC Data: 2025-12-31
STRONG SELL
92% Conf
Pending
Analysis scheduled

📊 MPT Key Takeaways

Revenue: $972.0M
Net Margin: -28.5%
Free Cash Flow: $230.8M
Current Ratio: N/A
Debt/Equity: 2.11x
EPS: $-0.46
AI Rating: STRONG SELL with 92% confidence

Is MPT a Good Investment? Thesis Analysis

Claude

Medical Properties Trust is experiencing severe operational distress with significant negative profitability across all major metrics despite maintaining positive operating cash flow. The company is burning through equity with negative net income of -$277M, negative operating margins of -24.4%, and deteriorating returns (ROE of -6.0%, ROA of -1.8%). High leverage (2.11x Debt/Equity) combined with negative interest coverage of -0.5x indicates substantial financial stress and limited ability to service debt obligations.

Why Buy MPT? Key Strengths

Claude
  • + Positive operating cash flow of $230.8M provides near-term liquidity relief
  • + Strong free cash flow margin of 23.7% relative to revenue suggests some underlying operational efficiency in cash generation
  • + Substantial asset base of $15.0B provides collateral and potential restructuring flexibility

MPT Investment Risks to Consider

Claude
  • ! Consistent negative profitability with -$277M net loss and -24.4% operating margin indicates fundamental operational problems
  • ! Critical negative interest coverage (-0.5x) signals inability to cover debt service from operating earnings, creating default risk
  • ! Elevated leverage ratio of 2.11x Debt/Equity ($9.7B long-term debt) with deteriorating equity position creates refinancing risk and limits financial flexibility
  • ! Declining revenue (-2.4% YoY) combined with operational losses suggests market headwinds in the healthcare real estate sector

Key Metrics to Watch

Claude
  • * Quarterly operating income trend and path to profitability
  • * Debt-to-EBITDA ratio and debt refinancing schedules
  • * Cash flow from operations sustainability and capital allocation decisions
  • * Revenue stabilization and occupancy rates at portfolio properties
  • * Interest coverage ratio recovery to positive territory

MPT Financial Metrics

Revenue
$972.0M
Net Income
$-277.0M
EPS (Diluted)
$-0.46
Free Cash Flow
$230.8M
Total Assets
$15.0B
Cash Position
$540.9M

💡 AI Analyst Insight

The 23.7% free cash flow margin provides substantial flexibility for dividends, buybacks, and strategic investments. The current ratio below 1.0x warrants monitoring of short-term liquidity.

MPT Profitability Ratios

Gross Margin N/A
Operating Margin -24.4%
Net Margin -28.5%
ROE -6.0%
ROA -1.8%
FCF Margin 23.7%

MPT vs Default Sector

How MEDICAL PROPERTIES TRUST INC compares to Default sector averages

Net Margin
MPT -28.5%
vs
Sector Avg 12.0%
MPT Sector
ROE
MPT -6.0%
vs
Sector Avg 15.0%
MPT Sector
Current Ratio
MPT 0.0x
vs
Sector Avg 1.8x
MPT Sector
Debt/Equity
MPT 2.1x
vs
Sector Avg 0.7x
MPT Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is MPT Overvalued or Undervalued?

Based on fundamental analysis, MEDICAL PROPERTIES TRUST INC shows some fundamental concerns relative to the Default sector in 2026.

Return on Equity
-6.0%
Sector avg: 15%
Net Profit Margin
-28.5%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
2.11x
Sector avg: 0.7x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

MPT Balance Sheet & Liquidity

Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
2.11x
Debt/Assets
69.3%
Interest Coverage
-0.47x
Long-term Debt
$9.7B

MPT 5-Year Financial Trend & Growth Analysis

MPT 5-year financial data: Year 2021: Revenue $1.5B, Net Income $374.7M, EPS N/A. Year 2022: Revenue $1.5B, Net Income $431.5M, EPS $0.81. Year 2023: Revenue $1.5B, Net Income $656.0M, EPS $1.11. Year 2024: Revenue $1.5B, Net Income $902.6M, EPS $1.50. Year 2025: Revenue $995.5M, Net Income -$556.5M, EPS $-0.93.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: MEDICAL PROPERTIES TRUST INC's revenue has declined by 36% over the 5-year period, indicating business contraction. The most recent EPS of $-0.93 indicates the company is currently unprofitable.

MPT Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
23.7%
Free cash flow / Revenue

MPT Quarterly Performance

Quarterly financial performance data for MEDICAL PROPERTIES TRUST INC including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2025 $225.8M -$77.7M $-0.13
Q2 2025 $240.4M -$98.4M $-0.16
Q1 2025 $223.8M -$118.3M $-0.20
Q3 2024 $225.8M $107.5M $0.18
Q2 2024 $266.6M -$9.2M $-0.02
Q1 2024 $271.3M $32.8M $0.05
Q3 2023 $306.6M $107.5M $0.18
Q2 2023 $337.4M -$9.2M $-0.02

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

MPT Capital Allocation

Operating Cash Flow
$230.8M
Cash generated from operations
Stock Buybacks
$23.4M
Shares repurchased (TTM)
Dividends
None
No dividend program

MPT SEC 10-K & 10-Q Filing Analysis

Access official SEC EDGAR filings for MEDICAL PROPERTIES TRUST INC (CIK: 0001287865)

📋 Recent SEC Filings

Date Form Document Action
Mar 19, 2026 4 xslF345X06/ownership.xml View →
Mar 19, 2026 4 xslF345X06/ownership.xml View →
Mar 19, 2026 4 xslF345X06/ownership.xml View →
Mar 19, 2026 4 xslF345X06/ownership.xml View →
Feb 26, 2026 10-K mpt-20251231.htm View →

Frequently Asked Questions about MPT

What is the AI rating for MPT?

MEDICAL PROPERTIES TRUST INC (MPT) has an AI rating of STRONG SELL with 92% confidence, based on fundamental analysis of SEC EDGAR filings.

What are MPT's key strengths?

Claude: Positive operating cash flow of $230.8M provides near-term liquidity relief. Strong free cash flow margin of 23.7% relative to revenue suggests some underlying operational efficiency in cash generation.

What are the risks of investing in MPT?

Claude: Consistent negative profitability with -$277M net loss and -24.4% operating margin indicates fundamental operational problems. Critical negative interest coverage (-0.5x) signals inability to cover debt service from operating earnings, creating default risk.

What is MPT's revenue and growth?

MEDICAL PROPERTIES TRUST INC reported revenue of $972.0M.

Does MPT pay dividends?

MEDICAL PROPERTIES TRUST INC does not currently pay dividends.

Where can I find MPT SEC filings?

Official SEC filings for MEDICAL PROPERTIES TRUST INC (CIK: 0001287865) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is MPT's EPS?

MEDICAL PROPERTIES TRUST INC has a diluted EPS of $-0.46.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is MPT a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, MEDICAL PROPERTIES TRUST INC has a STRONG SELL rating with 92% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is MPT stock overvalued or undervalued?

Valuation metrics for MPT: ROE of -6.0% (sector avg: 15%), net margin of -28.5% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy MPT stock in 2026?

Our dual AI analysis gives MEDICAL PROPERTIES TRUST INC a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is MPT's free cash flow?

MEDICAL PROPERTIES TRUST INC's operating cash flow is $230.8M, with capital expenditures of N/A. FCF margin is 23.7%.

How does MPT compare to other Default stocks?

Vs Default sector averages: Net margin -28.5% (avg: 12%), ROE -6.0% (avg: 15%), current ratio N/A (avg: 1.8).

Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 2, 2026 | Data as of: 2025-12-31 | Powered by Claude AI